Drug-drug interactions that matter

Top HIV Med. Jun-Jul 2006;14(2):88-92.

Abstract

It is increasingly difficult to keep track of information on drug-drug interactions in HIV therapeutics, and the clinical implications of much of the data reported are not immediately evident. Nevertheless, knowledge of drug-drug interactions is necessary to preserve antiretroviral efficacy and to avoid undue risk of toxicity. The following article reviews important drug-drug interactions and accumulating data on newer antiretroviral agents.

Publication types

  • Research Support, Non-U.S. Gov't
  • Review

MeSH terms

  • Anti-HIV Agents / administration & dosage
  • Anti-HIV Agents / pharmacology*
  • Drug Interactions*
  • Drug Synergism
  • Drug Therapy, Combination
  • HIV Infections / drug therapy*
  • HIV Protease Inhibitors / pharmacology
  • Humans
  • Reverse Transcriptase Inhibitors / pharmacology

Substances

  • Anti-HIV Agents
  • HIV Protease Inhibitors
  • Reverse Transcriptase Inhibitors